![Michael Wittekind](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Wittekind
No open positions remaining
Profile
Michael Wittekind worked as an Executive Director-Research at Amgen, Inc. from 2003 to 2007, an Associate Director at Bristol-Myers Squibb Pharmaceutical Research Institute, and a Chief Scientific Officer & Senior VP-Research at ContraFect Corp.
from 2014 to 2016.
He also worked as a Director-Process Development at Phylos, Inc. Dr. Wittekind holds a doctorate degree from the University of Wisconsin and a graduate degree from the University of Washington.
Former positions of Michael Wittekind
| Companies | Position | End |
|---|---|---|
| CONTRAFECT CORPORATION | Chief Tech/Sci/R&D Officer | 01/10/2016 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/11/2007 |
Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | - |
Phylos, Inc.
 Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and manufacturing services | Corporate Officer/Principal | - |
Training of Michael Wittekind
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phylos, Inc.
Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and manufacturing services | Commercial Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Pharmaceutical Research Institute | |
ContraFect Corp.
 ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
- Stock Market
- Insiders
- Michael Wittekind
